The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention.

Standard treatment of hyperglycemia in type 2 diabetes includes a pathway when “cost is a major issue.” Whether it’s just to do so remains unclear.

Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General.

Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics.

Ending AIDS requires normalizing justice-based approaches to HIV care and acknowledging how power dynamics shape popular narratives and practices.

Merits and drawbacks of U = U messaging are ethically and clinically complex, and drawbacks could harm patients in whom viral suppression is hard to achieve.

Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care.

Drs Oliva Kates and Monica Gandhi join Ethics Talk to discuss equity and public health messaging in ending the HIV epidemic.

Law doesn’t always adequately address unauthorized uses of individuals’ DNA. Ethics can help establish legal privacy protections that work.

Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?